{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T02:49:09Z","timestamp":1749178149041},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00284-021-02599-2","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T08:02:57Z","timestamp":1626768177000},"page":"3516-3525","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Comparative Study of ESBL Production Among Uropathogenic Escherichia coli Clinical Isolates from Pre- and Post-menopausal Women in Egypt"],"prefix":"10.1007","volume":"78","author":[{"given":"Ghada Hani","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marwa A.","family":"Yakout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"issue":"2","key":"2599_CR1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.4103\/ijp.IJP_200_17","volume":"50","author":"S Fatima","year":"2018","unstructured":"Fatima S, Muhammad IN, Usman S, Jamil S, Khan MN, Khan SI (2018) Incidence of multidrug resistance and extended-spectrum beta-lactamase expression in community-acquired urinary tract infection among different age groups of patients. Indian J Pharmacol 50(2):69\u201374. https:\/\/doi.org\/10.4103\/ijp.IJP_200_17","journal-title":"Indian J Pharmacol"},{"issue":"2","key":"2599_CR2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/1120009x.2017.1393587","volume":"30","author":"C Genovese","year":"2018","unstructured":"Genovese C, Davinelli S, Mangano K, Tempera G, Nicolosi D, Corsello S, Vergalito F, Tartaglia E, Scapagnini G, Di Marco R (2018) Effects of a new combination of plant extracts plus d-mannose for the management of uncomplicated recurrent urinary tract infections. J Chemother 30(2):107\u2013114. https:\/\/doi.org\/10.1080\/1120009x.2017.1393587","journal-title":"J Chemother"},{"issue":"2","key":"2599_CR3","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3390\/antibiotics3020143","volume":"3","author":"D Nicolosi","year":"2014","unstructured":"Nicolosi D, Tempera G, Genovese C, Furneri PM (2014) Anti-adhesion activity of A2-type proanthocyanidins (a cranberry major component) on uropathogenic E. coli and P. mirabilis strains. Antibiotics (Basel) 3(2):143\u2013154. https:\/\/doi.org\/10.3390\/antibiotics3020143","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"2599_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.idc.2013.09.003","volume":"28","author":"B Foxman","year":"2014","unstructured":"Foxman B (2014) Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am 28(1):1\u201313. https:\/\/doi.org\/10.1016\/j.idc.2013.09.003","journal-title":"Infect Dis Clin North Am"},{"key":"2599_CR5","doi-asserted-by":"publisher","first-page":"4192908","DOI":"10.1155\/2017\/4192908","volume":"2017","author":"P Miotla","year":"2017","unstructured":"Miotla P, Romanek-Piva K, Bogusiewicz M, Markut-Miotla E, Adamiak A, Wr\u00f3bel A, Zebrowska M, Wawrysiuk S, Mendyk K, Rechberger E, Jakubczak A, Rechberger T (2017) Antimicrobial resistance patterns in women with positive urine culture: does menopausal status make a significant difference? BioMed Res Int 2017:4192908. https:\/\/doi.org\/10.1155\/2017\/4192908","journal-title":"BioMed Res Int"},{"key":"2599_CR6","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.2147\/IDR.S174506","volume":"11","author":"J Bubpamala","year":"2018","unstructured":"Bubpamala J, Khuntayaporn P, Thirapanmethee K, Montakantikul P, Santanirand P, Chomnawang MT (2018) Phenotypic and genotypic characterizations of extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Drug Resist 11:2151\u20132157. https:\/\/doi.org\/10.2147\/IDR.S174506","journal-title":"Infect Drug Resist"},{"issue":"4","key":"2599_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.idc.2009.06.002","volume":"23","author":"LF Chen","year":"2009","unstructured":"Chen LF, Chopra T, Kaye KS (2009) Pathogens resistant to antibacterial agents. Infect Dis Clin North Am 23(4):817\u2013845. https:\/\/doi.org\/10.1016\/j.idc.2009.06.002","journal-title":"Infect Dis Clin North Am"},{"key":"2599_CR8","first-page":"11","volume":"17","author":"S Ghafourian","year":"2015","unstructured":"Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z (2015) Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol 17:11\u201321","journal-title":"Curr Issues Mol Biol"},{"issue":"1","key":"2599_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.sjbs.2014.08.002","volume":"22","author":"S Shaikh","year":"2015","unstructured":"Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA (2015) Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J Biol Sci 22(1):90\u2013101. https:\/\/doi.org\/10.1016\/j.sjbs.2014.08.002","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"2599_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s15010-011-0132-6","volume":"39","author":"S Meier","year":"2011","unstructured":"Meier S, Weber R, Zbinden R, Ruef C, Hasse B (2011) Extended-spectrum beta-lactamase-producing gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39(4):333\u2013340. https:\/\/doi.org\/10.1007\/s15010-011-0132-6","journal-title":"Infection"},{"issue":"6","key":"2599_CR11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jinf.2008.09.034","volume":"57","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD (2008) Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J Infect 57(6):441\u2013448. https:\/\/doi.org\/10.1016\/j.jinf.2008.09.034","journal-title":"J Infect"},{"issue":"2","key":"2599_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ajg.2019.01.003","volume":"20","author":"N Tharwat","year":"2019","unstructured":"Tharwat N, El-Sherif R, Elnagdy S, Marzaban R, Amer S (2019) Virulent Escherichia coli strains among Egyptian patients with acute diarrhoea versus urinary tract infection, and their antibiotic susceptibility. Arab J Gastroenterol 20(2):74\u201380. https:\/\/doi.org\/10.1016\/j.ajg.2019.01.003","journal-title":"Arab J Gastroenterol"},{"issue":"2","key":"2599_CR13","doi-asserted-by":"publisher","first-page":"e14444","DOI":"10.5812\/jjm.14444","volume":"11","author":"W Gawad","year":"2018","unstructured":"Gawad W, Helmy O, Tawakkol W, Hashem A (2018) Antimicrobial resistance, biofilm formation, and phylogenetic grouping of uropathogenic Escherichia coli isolates in Egypt: the role of efflux pump-mediated resistance Jundishapur. J Microbiol 11(2):e14444. https:\/\/doi.org\/10.5812\/jjm.14444","journal-title":"J Microbiol"},{"issue":"2","key":"2599_CR14","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jgar.2014.01.003","volume":"2","author":"MS Alabsi","year":"2014","unstructured":"Alabsi MS, Ghazal A, Sabry SA, Alasaly MM (2014) Association of some virulence genes with antibiotic resistance among uropathogenic Escherichia coli isolated from urinary tract infection patients in Alexandria, Egypt: a hospital-based study. J Glob Antimicrob Resist 2(2):83\u201386. https:\/\/doi.org\/10.1016\/j.jgar.2014.01.003","journal-title":"J Glob Antimicrob Resist"},{"key":"2599_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1476-0711-12-7","volume":"12","author":"SM Al-Mayahie","year":"2013","unstructured":"Al-Mayahie SM (2013) Phenotypic and genotypic comparison of ESBL production by vaginal Escherichia coli isolates from pregnant and non-pregnant women. Ann Clin Microbiol Antimicrob 12:7. https:\/\/doi.org\/10.1186\/1476-0711-12-7","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2599_CR16","unstructured":"Bergey\u2019s manual of determinative bacteriology identification flow charts (2015). https:\/\/static1.squarespace.com\/static\/54c7f25fe4b0447c7f8aed4b\/t\/5504c972e4b06ae7c7462e69\/1426377074561\/IDFlowcharts.pdf. Accessed 26 May 2019"},{"key":"2599_CR17","volume-title":"Performance standards for antimicrobial susceptibility testing: CLSI supplement M100S","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2016","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2016) Performance standards for antimicrobial susceptibility testing: CLSI supplement M100S, 26th edn. Clinical and Laboratory Standards Institute, Wayne","edition":"26"},{"key":"2599_CR18","volume-title":"Biochemical tests for identification of medical bacteria","author":"JF MacFadden","year":"2000","unstructured":"MacFadden JF (2000) Biochemical tests for identification of medical bacteria, 3rd edn. The Williams & Wilkins Co, USA","edition":"3"},{"key":"2599_CR19","first-page":"49","volume":"36","author":"AW Bauer","year":"1966","unstructured":"Bauer AW, Kirby WM, Sherris JC, Turck M (1966) Antibiotic susceptibility testing by a standardized single disk method. Tech Bull Regist Med Technol 36:49\u201352","journal-title":"Tech Bull Regist Med Technol"},{"key":"2599_CR20","unstructured":"The European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2021) Clinical breakpoints - breakpoints and guidance. https:\/\/www.eucast.org\/clinical_breakpoints\/. Accessed 6 Jan 2021"},{"issue":"3","key":"2599_CR21","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1128\/jcm.02130-10","volume":"49","author":"H Garrec","year":"2011","unstructured":"Garrec H, Drieux-Rouzet L, Golmard JL, Jarlier V, Robert J (2011) Comparison of nine phenotypic methods for detection of extended-spectrum beta-lactamase production by Enterobacteriaceae. J Clin Microbiol 49(3):1048\u20131057. https:\/\/doi.org\/10.1128\/jcm.02130-10","journal-title":"J Clin Microbiol"},{"key":"2599_CR22","volume-title":"Performance standards for antimicrobial susceptibility testing. 18th informational supplement: M100\u2013S18","author":"PA Wayne","year":"2008","unstructured":"Wayne PA (2008) Performance standards for antimicrobial susceptibility testing. 18th informational supplement: M100\u2013S18. Clinical and Laboratory Standards Institute, Pennsylvania"},{"key":"2599_CR23","volume-title":"Molecular cloning: laboratory manual","author":"J Sambrook","year":"2011","unstructured":"Sambrook J, Russell DW (2011) Molecular cloning: laboratory manual, 3rd edn. Cold Spring Harbor Laboratory Press, New York","edition":"3"},{"issue":"5","key":"2599_CR24","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1128\/aac.49.5.1823-1829.2005","volume":"49","author":"E Machado","year":"2005","unstructured":"Machado E, Cant\u00f3n R, Baquero F, Gal\u00e1n JC, Roll\u00e1n A, Peixe L, Coque TM (2005) Integron content of extended-spectrum-beta-lactamase-producing Escherichia coli strains over 12 years in a single hospital in Madrid Spain. Antimicrob Agents Chemother 49(5):1823\u20131829. https:\/\/doi.org\/10.1128\/aac.49.5.1823-1829.2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2599_CR25","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u2013281. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"2599_CR26","doi-asserted-by":"publisher","first-page":"e030266","DOI":"10.1136\/bmjopen-2019-030266","volume":"10","author":"P Shamsrizi","year":"2020","unstructured":"Shamsrizi P, Gladstone BP, Carrara E, Luise D, Cona A, Bovo C, Tacconelli E (2020) Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis. BMJ Open 10(1):e030266. https:\/\/doi.org\/10.1136\/bmjopen-2019-030266","journal-title":"BMJ Open"},{"key":"2599_CR27","doi-asserted-by":"publisher","first-page":"4846159","DOI":"10.1155\/2018\/4846159","volume":"2018","author":"M Abayneh","year":"2018","unstructured":"Abayneh M, Tesfaw G, Abdissa A (2018) Isolation of extended-spectrum \u03b2-lactamase- (ESBL-) producing Escherichia coli and Klebsiella pneumoniae from patients with community-onset urinary tract infections in Jimma university specialized hospital, Southwest Ethiopia. Can J Infect Dis Med Microbiol 2018:4846159. https:\/\/doi.org\/10.1155\/2018\/4846159","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2599_CR28","doi-asserted-by":"publisher","first-page":"3358","DOI":"10.3389\/fmicb.2018.03358","volume":"9","author":"L Falgenhauer","year":"2019","unstructured":"Falgenhauer L, Imirzalioglu C, Oppong K, Akenten CW, Hogan B, Krumkamp R, Poppert S, Levermann V, Schwengers O, Sarpong N, Owusu-Dabo E, May J, Eibach D (2019) Detection and characterization of ESBL-producing Escherichia coli from humans and poultry in Ghana. Front Microbiol 9:3358. https:\/\/doi.org\/10.3389\/fmicb.2018.03358","journal-title":"Front Microbiol"},{"key":"2599_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.meegid.2018.04.005","volume":"61","author":"Y Chong","year":"2018","unstructured":"Chong Y, Shimoda S, Shimono N (2018) Current epidemiology, genetic evolution and clinical impact of extended-spectrum \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect Genet Evol 61:185\u2013188. https:\/\/doi.org\/10.1016\/j.meegid.2018.04.005","journal-title":"Infect Genet Evol"},{"key":"2599_CR30","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization (WHO)","year":"2014","unstructured":"World Health Organization (WHO) (2014) Antimicrobial resistance: global report on surveillance. WHO Library Cataloguing-in-Publication, Geneva"},{"issue":"6","key":"2599_CR31","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jinf.2015.08.012","volume":"71","author":"E Esteve-Palau","year":"2015","unstructured":"Esteve-Palau E, Solande G, Sanchez F, Sorli L, Montero M, Guerri R, Villar J, Grau S, Horcajada JP (2015) Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: a matched cohort study. J Infect 71(6):667\u2013674. https:\/\/doi.org\/10.1016\/j.jinf.2015.08.012","journal-title":"J Infect"},{"key":"2599_CR32","doi-asserted-by":"publisher","first-page":"7656752","DOI":"10.1155\/2018\/7656752","volume":"2018","author":"DS Lee","year":"2018","unstructured":"Lee DS, Lee S-J, Choe H-S (2018) Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. BioMed Res Int 2018:7656752. https:\/\/doi.org\/10.1155\/2018\/7656752","journal-title":"BioMed Res Int"},{"issue":"2","key":"2599_CR33","doi-asserted-by":"publisher","first-page":"e22540","DOI":"10.5812\/archcid.22540","volume":"10","author":"I Al-Subol","year":"2015","unstructured":"Al-Subol I, Youssef N (2015) Prevalence of CTX-M, TEM and SHV beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae isolated from Aleppo university hospitals, Aleppo. Syria Arch Clin Infect Dis 10(2):e22540. https:\/\/doi.org\/10.5812\/archcid.22540","journal-title":"Syria Arch Clin Infect Dis"},{"key":"2599_CR34","doi-asserted-by":"publisher","first-page":"3026851","DOI":"10.1155\/2018\/3026851","volume":"2018","author":"A Alqasim","year":"2018","unstructured":"Alqasim A, Abu Jaffal A, Alyousef AA (2018) Prevalence of multidrug resistance and extended-spectrum \u03b2-lactamase carriage of clinical uropathogenic Escherichia coli isolates in Riyadh. Saudi Arabia Int J Microbiol 2018:3026851. https:\/\/doi.org\/10.1155\/2018\/3026851","journal-title":"Saudi Arabia Int J Microbiol"},{"issue":"2","key":"2599_CR35","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1089\/mdr.2013.0088","volume":"20","author":"K Rajapandiyan","year":"2014","unstructured":"Rajapandiyan K, Shanthi S, Vijayalakshmi P, Daisy P, Murugan M, Ranjitsingh AJ (2014) Prevalence of extended-spectrum beta-lactamase-producing multidrug-resistant Escherichia coli among isolates from community-acquired infections and in silico structural modeling of an ESBL protein. Microb Drug Resist 20(2):170\u2013176. https:\/\/doi.org\/10.1089\/mdr.2013.0088","journal-title":"Microb Drug Resist"},{"key":"2599_CR36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12941-018-0286-5","volume":"17","author":"F Ram\u00edrez Castillo","year":"2018","unstructured":"Ram\u00edrez Castillo F, Moreno Flores A, Gonz\u00e1lez F, D\u00edaz F, Harel J, Guerrero-Barrera A (2018) An evaluation of multidrug-resistant Escherichia coli isolates in urinary tract infections from Aguascalientes, Mexico: cross-sectional study. Ann Clin Microbiol Antimicrob 17:34. https:\/\/doi.org\/10.1186\/s12941-018-0286-5","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"10","key":"2599_CR37","doi-asserted-by":"publisher","first-page":"e27517","DOI":"10.5812\/jjm.27517","volume":"8","author":"AS Moini","year":"2015","unstructured":"Moini AS, Soltani B, Taghavi Ardakani A, Moravveji A, Erami M, Haji Rezaei M, Namazi M (2015) Multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolated from patients in Kashan. Iran Jundishapur J Microbiol 8(10):e27517. https:\/\/doi.org\/10.5812\/jjm.27517","journal-title":"Iran Jundishapur J Microbiol"},{"key":"2599_CR38","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4103\/0976-9668.175020","volume":"7","author":"R Dehbanipour","year":"2016","unstructured":"Dehbanipour R, Rastaghi S, Sedighi M, Maleki N, Faghri J (2016) High prevalence of multidrug-resistance uropathogenic Escherichia coli strains, Isfahan. Iran J Nat Sci Biol Med 7:22. https:\/\/doi.org\/10.4103\/0976-9668.175020","journal-title":"Iran J Nat Sci Biol Med"},{"key":"2599_CR39","doi-asserted-by":"publisher","first-page":"6525826","DOI":"10.1155\/2020\/6525826","volume":"2020","author":"R Pandit","year":"2020","unstructured":"Pandit R, Awal B, Shrestha SS, Joshi G, Rijal BP, Parajuli NP (2020) Extended-spectrum \u03b2-lactamase (ESBL) genotypes among multidrug-resistant uropathogenic Escherichia coli clinical isolates from a teaching hospital of Nepal. Interdiscip Perspect Infect Dis 2020:6525826. https:\/\/doi.org\/10.1155\/2020\/6525826","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"2599_CR40","first-page":"191","volume":"10","author":"O Ahmed","year":"2013","unstructured":"Ahmed O, Omar A, Asghar A, El hassan M (2013) Prevalence of TEM, SHV and CTX-M genes in Escherichia coli and Klebsiella spp. urinary isolates from Sudan with confirmed ESBL phenotype. Life Sci J 10:191\u2013195","journal-title":"Life Sci J"},{"issue":"1","key":"2599_CR41","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1038\/s41598-020-59772-z","volume":"10","author":"NA Hassuna","year":"2020","unstructured":"Hassuna NA, Khairalla AS, Farahat EM, Hammad AM, Abdel-Fattah M (2020) Molecular characterization of extended-spectrum beta lactamase- producing E. coli recovered from community-acquired urinary tract infections in Upper Egypt. Sci Rep 10(1):2772. https:\/\/doi.org\/10.1038\/s41598-020-59772-z","journal-title":"Sci Rep"},{"issue":"1","key":"2599_CR42","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12879-019-3838-1","volume":"19","author":"O Ouchar Mahamat","year":"2019","unstructured":"Ouchar Mahamat O, Lounnas M, Hide M, Dumont Y, Tidjani A, Kamougam K, Abderrahmane M, Benavides J, Solassol J, Ba\u00f1uls A-L, Jean-Pierre H, Carri\u00e8re C, Godreuil S (2019) High prevalence and characterization of extended-spectrum \u00df-lactamase producing enterobacteriaceae in Chadian hospitals. BMC Infect Dis 19(1):205. https:\/\/doi.org\/10.1186\/s12879-019-3838-1","journal-title":"BMC Infect Dis"},{"key":"2599_CR43","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1476-0711-13-4","volume":"13","author":"M Al-agamy","year":"2014","unstructured":"Al-agamy M, Shibl A, Hafez M, Al-Ahdal M, Memish Z, Khubnani H (2014) Molecular characteristics of extended-spectrum \u03b2-lactamase-producing Escherichia coli in riyadh: emergence of CTX-M-15-producing E. coli ST131. Ann Clin Microbiol Antimicrob 13:4. https:\/\/doi.org\/10.1186\/1476-0711-13-4","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"2599_CR44","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1128\/aac.01993-13","volume":"58","author":"G Valenza","year":"2014","unstructured":"Valenza G, Nickel S, Pfeifer Y, Eller C, Krupa E, Lehner-Reindl V, H\u00f6ller C (2014) Extended-spectrum-\u03b2-lactamase-producing Escherichia coli as intestinal colonizers in the German community. Antimicrob Agents Chemother 58(2):1228\u20131230. https:\/\/doi.org\/10.1128\/aac.01993-13","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2599_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","volume":"27","author":"DM Livermore","year":"2012","unstructured":"Livermore DM (2012) Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 27(2):128\u2013142. https:\/\/doi.org\/10.3904\/kjim.2012.27.2.128","journal-title":"Korean J Intern Med"},{"issue":"7","key":"2599_CR46","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1128\/AAC.00247-09","volume":"53","author":"JD Pitout","year":"2009","unstructured":"Pitout JD, Gregson DB, Campbell L, Laupland KB (2009) Molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli isolates causing bacteremia in the calgary health region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 53(7):2846\u20132851. https:\/\/doi.org\/10.1128\/AAC.00247-09","journal-title":"Antimicrob Agents Chemother"},{"key":"2599_CR47","doi-asserted-by":"publisher","first-page":"935842","DOI":"10.1155\/2014\/935842","volume":"2014","author":"D Ojdana","year":"2014","unstructured":"Ojdana D, Sacha P, Wieczorek P, Czaban S, Michalska A, Jaworowska J, Jurczak A, Poniatowski B, Tryniszewska E (2014) The occurrence of blaCTX-M, blaSHV, and blaTEM genes in extended-spectrum \u03b2-lactamase-positive strains of Klebsiella pneumoniae, Escherichia coli, and proteus mirabilis in Poland. Int J Antibiotic 2014:935842. https:\/\/doi.org\/10.1155\/2014\/935842","journal-title":"Int J Antibiotic"},{"key":"2599_CR48","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.3389\/fmicb.2019.02465","volume":"10","author":"E Sepp","year":"2019","unstructured":"Sepp E, Andreson R, Balode A, Bilozor A, Brauer A, Egorova S, Huik K, Ivanova M, Kaftyreva L, K\u00f5ljalg S, K\u00f5ressaar T, Makarova M, Miciuleviciene J, Pai K, Remm M, R\u00f6\u00f6p T, Naaber P (2019) Phenotypic and molecular epidemiology of ESBL-, AmpC-, and carbapenemase-producing Escherichia coli in Northern and Eastern Europe. Front Microbiol 10:2465. https:\/\/doi.org\/10.3389\/fmicb.2019.02465","journal-title":"Front Microbiol"},{"issue":"1","key":"2599_CR49","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1093\/jac\/dku332","volume":"70","author":"TS Kjeldsen","year":"2015","unstructured":"Kjeldsen TS, Overgaard M, Nielsen SS, Bortolaia V, Jelsbak L, Sommer M, Guardabassi L, Olsen JE (2015) CTX-M-1 \u03b2-lactamase expression in Escherichia coli is dependent on cefotaxime concentration, growth phase and gene location. J Antimicrob Chemother 70(1):62\u201370. https:\/\/doi.org\/10.1093\/jac\/dku332","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2599_CR50","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","volume":"70","author":"JD Pitout","year":"2010","unstructured":"Pitout JD (2010) Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70(3):313\u2013333. https:\/\/doi.org\/10.2165\/11533040-000000000-00000","journal-title":"Drugs"},{"issue":"8","key":"2599_CR51","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2014.303","volume":"311","author":"L Mody","year":"2014","unstructured":"Mody L, Juthani-Mehta M (2014) Urinary tract infections in older women: a clinical review. JAMA 311(8):844\u2013854. https:\/\/doi.org\/10.1001\/jama.2014.303","journal-title":"JAMA"},{"key":"2599_CR52","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/s0924-8579(00)00350-2","volume":"17","author":"T Hooton","year":"2001","unstructured":"Hooton T (2001) Recurrent urinary tract infection in women (review). Int J Antimicrob Agents 17:259\u2013268. https:\/\/doi.org\/10.1016\/s0924-8579(00)00350-2","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"2599_CR53","doi-asserted-by":"publisher","first-page":"359","DOI":"10.12816\/0003256","volume":"13","author":"A Al-Badr","year":"2013","unstructured":"Al-Badr A, Al-Shaikh G (2013) Recurrent urinary tract infections management in women: a review. Sultan Qaboos Univ Med J 13(3):359\u2013367. https:\/\/doi.org\/10.12816\/0003256","journal-title":"Sultan Qaboos Univ Med J"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-021-02599-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-021-02599-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T04:09:01Z","timestamp":1628827741000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-021-02599-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["2599"],"URL":"https:\/\/doi.org\/10.1007\/s00284-021-02599-2","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Regarding ethical clarification required concerning the isolation of bacterial isolates form clinical specimens, this was carried out by nurses and technicians in the hospitals not by us. We only collected the subcultured isolates from the microbiology laboratories in these hospitals. Privacy and confidentiality of all patients\u2019 information was anonymized. Therefore, no need for ethical approval or consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}